Fidelity Investments’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Buy
462,630
+67,355
+17% +$268K ﹤0.01% 2698
2025
Q4
$1.39M Buy
395,275
+83,574
+27% +$286K ﹤0.01% 2731
2025
Q3
$1.02M Buy
311,701
+45,652
+17% +$144K ﹤0.01% 2794
2025
Q2
$652K Buy
266,049
+220,494
+484% +$1.12M ﹤0.01% 2876
2025
Q1
$304K Sell
45,555
-83,979
-65% -$830K ﹤0.01% 3088
2024
Q4
$1.63M Sell
129,534
-335,922
-72% -$5.06M ﹤0.01% 2507
2024
Q3
$8.6M Sell
465,456
-113,823
-20% -$2.33M ﹤0.01% 1969
2024
Q2
$12.5M Buy
579,279
+2,612
+0.5% +$60K ﹤0.01% 1806
2024
Q1
$15.5M Buy
576,667
+47,171
+9% +$1.34M ﹤0.01% 1739
2023
Q4
$15.9M Buy
529,496
+186,797
+55% +$4.12M ﹤0.01% 1703
2023
Q3
$7.02M Buy
342,699
+74,431
+28% +$1.35M ﹤0.01% 1935
2023
Q2
$5.33M Buy
268,268
+35,037
+15% +$708K ﹤0.01% 2051
2023
Q1
$4M Sell
233,231
-25,929
-10% -$508K ﹤0.01% 2159
2022
Q4
$5.07M Buy
259,160
+7
+0% +$129 ﹤0.01% 2115
2022
Q3
$4.14M Buy
259,153
+32,554
+14% +$508K ﹤0.01% 2229
2022
Q2
$3.12M Sell
226,599
-45,065
-17% -$537K ﹤0.01% 2363
2022
Q1
$4.31M Sell
271,664
-157,460
-37% -$2.72M ﹤0.01% 2410
2021
Q4
$9.37M Sell
429,124
-17,094
-4% -$466K ﹤0.01% 2144
2021
Q3
$13.3M Sell
446,218
-112,618
-20% -$4.1M ﹤0.01% 2002
2021
Q2
$24.8M Sell
558,836
-184,600
-25% -$8.02M ﹤0.01% 1754
2021
Q1
$33M Sell
743,436
-83,200
-10% -$4.57M ﹤0.01% 1577
2020
Q4
$45.3M Buy
826,636
+15,300
+2% +$558K ﹤0.01% 1358
2020
Q3
$18.5M Sell
811,336
-189,443
-19% -$4.67M ﹤0.01% 1592
2020
Q2
$20.9M Sell
1,000,779
-148,808
-13% -$2.68M ﹤0.01% 1529
2020
Q1
$16M Sell
1,149,587
-124,000
-10% -$2.46M ﹤0.01% 1495
2019
Q4
$29M Sell
1,273,587
-86,200
-6% -$1.44M ﹤0.01% 1449
2019
Q3
$15.8M Hold
1,359,787
﹤0.01% 1660
2019
Q2
$20.4M Sell
1,359,787
-105,312
-7% -$1.84M ﹤0.01% 1616
2019
Q1
$25.7M Hold
1,465,099
﹤0.01% 1483
2018
Q4
$21.7M Buy
1,465,099
+392,900
+37% +$6.52M ﹤0.01% 1519
2018
Q3
$26.4M Buy
+1,072,199
New +$23.3M ﹤0.01% 1567

Other funds holding RCKT